Literature DB >> 2876445

Neuroanatomical, neuropharmacological and neurobiochemical target systems for antipsychotic activity of neuroleptics.

A Delini-Stula.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 2876445     DOI: 10.1055/s-2007-1017171

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  7 in total

Review 1.  Clozapine--pharmacokinetic investigations and biochemical effects in man.

Authors:  M Ackenheil
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Clinical experience with clozapine in Germany.

Authors:  H Helmchen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Savoxepine: invalidation of an "atypical" neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patients.

Authors:  H Wetzel; K Wiedemann; F Holsboer; O Benkert
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Effect of clozapine upon schedule-induced polydipsia (SIP) resembles neither the actions of dopamine D1 nor D2 blockade.

Authors:  M Didriksen; G M Olsen; A V Christensen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.

Authors:  Amarendra N Singh; Cia Barlas; Huma Saeedi; Ram K Mishra
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

Review 6.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

7.  A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.

Authors:  A N Singh; C Barlas; S Singh; P Franks; R K Mishra
Journal:  J Psychiatry Neurosci       Date:  1996-01       Impact factor: 6.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.